Company / Current Assets
NovoCure Ltd Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$646.7M
FY2025
5-year range
$646.7M / $1.1B
FY2021-FY2025
Trend
-41.6%
vs FY2024
Sector context
#98 of 165
Health Care
What the data says
At $647M, NovoCure Ltd's current assets ranks #98 of 165 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $245M in FY2017 to $1.1B in FY2022.
Based on SEC 10-K filings.
$647M in FY2025 with a 5-year CAGR of -8.3%.
Declined from $1.0B to $647M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -16.5%
- 5-Year CAGR
- -8.3%
- 10-Year CAGR
- -
Sector benchmark
#98 of 165 in Health CareTop 59% of 165This company $646.7M Sector average $5.2B
▼
-87.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -8.3%, indicating a declining trend.
- In FY2025, current assets decreased 41.6% year-over-year.
- Ranks #98 out of 165 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $646.7M | -41.6% |
| FY2024 | $1.1B | +7.0% |
| FY2023 | $1.0B | -6.9% |
| FY2022 | $1.1B | +3.5% |
| FY2021 | $1.1B | +7.4% |
| FY2020 | $999.4M | +127.2% |
| FY2019 | $439.9M | +36.9% |
| FY2018 | $321.4M | +31.1% |
| FY2017 | $245.1M | -6.4% |
| FY2016 | $261.9M | -10.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026